Deals & Cases
Schellenberg Wittmer advises Marubeni Corporation on its acquisition of TOLUS Group AG
01.09.2026
Schellenberg Wittmer acted as Swiss counsel for Marubeni Corporation on the acquisition of Swiss TOLUS Group AG.
Deals & Cases
01.09.2026
Schellenberg Wittmer acted as Swiss counsel for Marubeni Corporation on the acquisition of Swiss TOLUS Group AG.
Arbitration Case Alert
20.08.2026
Newsletters
01.09.2026
Newsflashes
20.08.2026
Deals & Cases
25.08.2026
Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Evax AG. Evax AG is a Swiss biotech company focused on equine health.
Newsflashes
19.08.2026
Deals & Cases
01.09.2026
Schellenberg Wittmer acted as Swiss counsel for Marubeni Corporation on the acquisition of Swiss TOLUS Group AG.
Deals & Cases
25.08.2026
Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Evax AG. Evax AG is a Swiss biotech company focused on equine health.
Newsflashes
20.08.2026
Newsletters
01.09.2026
Arbitration Case Alert
20.08.2026
Newsflashes
19.08.2026
Deals & Cases
01.09.2026
Schellenberg Wittmer acted as Swiss counsel for Marubeni Corporation on the acquisition of Swiss TOLUS Group AG.
Newsletters
01.09.2026
Deals & Cases
25.08.2026
Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Evax AG. Evax AG is a Swiss biotech company focused on equine health.
Arbitration Case Alert
20.08.2026
Newsflashes
20.08.2026
Newsflashes
19.08.2026